Clinical Trial Update: A Study of Loco-Regional Liposomal Bupivacaine Injection [Phase 4]

View source ↗

Summary

A Mayo Clinic-sponsored Phase 4 trial of loco-regional liposomal bupivacaine injection for peripheral arterial disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• liposomal bupivacaine injection (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Mayo Clinic | Conditions: Peripheral Arterial Disease | Phase 4 | Status: TERMINATED